Spots Global Cancer Trial Database for disease free survival
Every month we try and update this database with for disease free survival cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) | NCT02260505 | Gastrointestina... Resected Gastro... Non-metastatic High Risk of Re... KIT Gene Mutati... | Imatinib mainte... | 18 Years - | Centre Leon Berard | |
| Endoscopic Versus Surgical Treatment for T1 Colorectal Cancer | NCT04150081 | Colorectal Canc... | Surgery or Endo... | - | Hospital Clinic of Barcelona | |
| Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer | NCT01090830 | Non-Small-Cell ... | Belinostat, car... | 18 Years - | Holy Cross Hospital, Florida | |
| Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma | NCT04778956 | Nasopharyngeal ... PD-1 Surgery | Toripalimab salvage surgery | 18 Years - 70 Years | Sun Yat-sen University | |
| Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer | NCT01090830 | Non-Small-Cell ... | Belinostat, car... | 18 Years - | Holy Cross Hospital, Florida | |
| Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients | NCT00352391 | Head and Neck C... Lung Cancer | Assessments | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma | NCT00273910 | High-Risk Melan... | gp100:209-217 (... Montanide ISA-5... Imiquimod | 7 Years - | National Institutes of Health Clinical Center (CC) | |
| A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy | NCT02776527 | Gastric Cancer | Apatinib Mesyla... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma | NCT03601689 | Rectal Neoplasm... | rectal resectio... | 18 Years - | Moroccan Society of Surgery | |
| Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection | NCT03779035 | Cholangiocarcin... Gall Bladder Ca... | Gemcitabine Capecitabine | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy | NCT04989647 | Cervical Cancer | No adjuvant the... Adjuvant radiot... | 18 Years - 85 Years | The Central and Eastern European Gynecologic Oncology Group | |
| SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients | NCT03448549 | Colorectal Canc... Adjuvant Chemot... | Oxaliplatin Tegafur，gimerac... Xeloda | 18 Years - | Peking University Cancer Hospital & Institute | |
| Efficacy of Adjuvant Mitotane Treatment (ADIUVO) | NCT00777244 | Adrenocortical ... | MITOTANE | 18 Years - | University of Turin, Italy | |
| Efficacy of Adjuvant Mitotane Treatment (ADIUVO) | NCT00777244 | Adrenocortical ... | MITOTANE | 18 Years - | University of Turin, Italy | |
| The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer | NCT03923335 | Colorectal Neop... | DNA methylation... | 40 Years - 70 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer | NCT00332852 | Breast Cancer | Letrozole | 18 Years - | Novartis | |
| The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients | NCT03770559 | Pancreatic Canc... Surgery | Minimal Invasiv... Open RAMPS | 18 Years - | Peking Union Medical College Hospital | |
| Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR) | NCT01301820 | Acute Myeloid L... | azacitidine Lenalidomide | 60 Years - 75 Years | French Innovative Leukemia Organisation | |
| Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma | NCT00273910 | High-Risk Melan... | gp100:209-217 (... Montanide ISA-5... Imiquimod | 7 Years - | National Institutes of Health Clinical Center (CC) | |
| Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma | NCT03601689 | Rectal Neoplasm... | rectal resectio... | 18 Years - | Moroccan Society of Surgery | |
| Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients | NCT01192230 | Carcinoma, Non-... | Endostatins Docetaxel | 18 Years - 80 Years | Fudan University | |
| Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study | NCT04245644 | Disease Free Su... Overall Surviva... Pancreatic Canc... | use of targeted... | 18 Years - | IRCCS San Raffaele | |
| Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer | NCT00902954 | Breast Cancer | anastrozole letrozole exemestane | - | Fudan University | |
| The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients | NCT03770559 | Pancreatic Canc... Surgery | Minimal Invasiv... Open RAMPS | 18 Years - | Peking Union Medical College Hospital | |
| T1 Squamous Cell Carcinomas of the Lip | NCT05610293 | Lip Lip Cancer Lip SCC Squamous Cell C... Squamous Cell C... Surgery Surgical Margin Recurrence Metastasis Tumor Free Marg... | 18 Years - | Maastricht University Medical Center | ||
| A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma | NCT01041482 | Renal Cell Carc... | sorafenib | 18 Years - 70 Years | ChineseAMS | |
| SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients | NCT03448549 | Colorectal Canc... Adjuvant Chemot... | Oxaliplatin Tegafur，gimerac... Xeloda | 18 Years - | Peking University Cancer Hospital & Institute | |
| Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection | NCT03779035 | Cholangiocarcin... Gall Bladder Ca... | Gemcitabine Capecitabine | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients | NCT02376413 | Local Recurrenc... | Breast surgery Chemotherapy or... Radiation thera... | 18 Years - 65 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia | NCT03686345 | Core Binding Fa... | Midostaurin | 18 Years - 65 Years | Niguarda Hospital | |
| Photon Therapy Versus Proton Therapy in Early Tonsil Cancer. | NCT03829033 | Tonsil Cancer | Radiotherapy | 18 Years - | Lund University Hospital | |
| Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study | NCT04245644 | Disease Free Su... Overall Surviva... Pancreatic Canc... | use of targeted... | 18 Years - | IRCCS San Raffaele | |
| Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial | NCT03038256 | Rectal Cancer Pathological Co... Disease Free Su... | concurrent cape... concurrent cape... | 18 Years - 75 Years | Peking University People's Hospital | |
| A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer | NCT04138992 | Disease Free Su... | bevacizumab DDP Docetaxel radiotherapy | 18 Years - 65 Years | Air Force Military Medical University, China | |
| Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum | NCT06096493 | Rectal Cancer | curative surger... | 18 Years - 90 Years | South Valley University | |
| A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer | NCT04138992 | Disease Free Su... | bevacizumab DDP Docetaxel radiotherapy | 18 Years - 65 Years | Air Force Military Medical University, China | |
| Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma | NCT04778956 | Nasopharyngeal ... PD-1 Surgery | Toripalimab salvage surgery | 18 Years - 70 Years | Sun Yat-sen University | |
| T1 Squamous Cell Carcinomas of the Lip | NCT05610293 | Lip Lip Cancer Lip SCC Squamous Cell C... Squamous Cell C... Surgery Surgical Margin Recurrence Metastasis Tumor Free Marg... | 18 Years - | Maastricht University Medical Center | ||
| Endoscopic Versus Surgical Treatment for T1 Colorectal Cancer | NCT04150081 | Colorectal Canc... | Surgery or Endo... | - | Hospital Clinic of Barcelona | |
| The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer | NCT03923335 | Colorectal Neop... | DNA methylation... | 40 Years - 70 Years | Sixth Affiliated Hospital, Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
